GLPcompareGLPcompare
DrugsPricesProvidersCompareShortagesEvidenceSupplementsWatchlist
HomePricesWegovy HD
US self-pay prices

Wegovy HD price without insurance

Wegovy HD contains semaglutide and is made by Novo Nordisk. Its lowest current self-pay price is $399/28 days, across 1 sourced offer. Prices below are by form and dose, each with its seller, conditions and check date.

Wegovy HD 7.2 mg injection

Once weekly

Advertised entry price

$399/28 days

28-day supply

≈ $427.50 per 30 days at this quoted rate

Checked Sep 30, 2026

Wegovy HD pen (7.2 mg)

NovoCare (Novo Nordisk) · Manufacturer direct

self-pay cash, 7.2 mg dose

Price conditions

self-pay cash, 7.2 mg dose

One box contains four weekly pens. This is the HD maintenance dose, not a treatment starting dose. The $199 introduction applies only to 0.25 and 0.5 mg standard Wegovy. Prescription, eligibility and restrictions apply.

28-day supply

Published maintenance dose

$399/28 days

28-day supply

≈ $427.50 per 30 days at this quoted rate

Checked Sep 30, 2026

At 7.2 mg

Wegovy HD pen (7.2 mg)

NovoCare (Novo Nordisk) · Manufacturer direct

Published price at 7.2 mg

Price conditions

Published price at 7.2 mg

One box contains four weekly pens. This is the HD maintenance dose, not a treatment starting dose. The $199 introduction applies only to 0.25 and 0.5 mg standard Wegovy. Prescription, eligibility and restrictions apply.

28-day supply

Every cash quote was checked on or after Sep 26, 2026. Each quote shows its own check date. A quoted dose is not a dosing recommendation. How we source prices

Every sourced offer

All Wegovy HD offers

Manufacturer, pharmacy and telehealth quotes for Wegovy HD itself. Compounded semaglutide is a different, unapproved product and is listed on the main price page.

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

Compare every GLP-1 price
Trial results

What Wegovy HD showed in trials

Each result belongs to its named trial and dose. Trial averages do not predict an individual's result.

Wegovy HD 7.2 mg injection

−18.7% (-18.7% at 72 wks · STEP UP · 7.2 mg weekly (Wegovy HD))

STEP UP · -18.7% at 72 wks

7.2 mg weekly (Wegovy HD)

Accounts for treatment discontinuation

US prescribing information

Approved uses

Eligibility, contraindications and warnings are in the full prescribing information.

Wegovy HD 7.2 mg injection

Weight management in adults with obesity, or overweight with a weight-related condition. The 7.2 mg dose is for adults who tolerate 2.4 mg and need additional weight reduction.

US prescribing information (Wegovy HD 7.2 mg injection prescribing information)

Reviewed Sep 22, 2026

FDA shortage status

Is Wegovy HD in shortage?

No shortage reported

No shortage is listed in the latest complete FDA check. The FDA does list discontinuation notices for specific presentations. This status covers semaglutide as a whole; last complete check Oct 9, 2026. National reporting does not confirm stock at your pharmacy.

All GLP-1 shortage reports
Questions

Wegovy HD cost: common questions

How much does Wegovy HD cost without insurance?

$399/28 days at NovoCare (Novo Nordisk) (≈ $427.50 per 30 days at this quoted rate). These are self-pay prices from the sellers' own pages, not insurance estimates; the conditions and refill rules listed with each quote apply.

What is Wegovy HD approved for?

Weight management in adults with obesity, or overweight with a weight-related condition. The 7.2 mg dose is for adults who tolerate 2.4 mg and need additional weight reduction.

Is Wegovy HD in shortage?

No shortage is listed in the latest complete FDA check. The FDA does list discontinuation notices for specific presentations. This status covers semaglutide as a whole; last complete check Oct 9, 2026. Confirm local stock with your pharmacy.

Semaglutide: evidence and safetyOzempic priceWegovy priceWegovy vs Wegovy HD
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.
GLPcompareGLPcompare

The live, fully-cited reference for the GLP-1 ecosystem. Every figure traces to its source. Informational only, not medical advice.

Product

  • Drugs
  • Prices
  • Providers
  • Compare
  • Shortages
  • Evidence
  • Supplements

Legal

  • Methodology
  • About
  • News
  • Price updates
  • Privacy Policy
  • Terms of Service
  • Support

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

© 2026 GLPcompare. All rights reserved.

Fazier #5 Product of the DayGLPcompare on LaunchNestFeatured on SaaSCityFeatured on LaunchBuffLeave a review for GLPcompare on Indie Need
How much weight loss did Wegovy HD show in trials?

In STEP UP, 7.2 mg weekly (Wegovy HD) showed a mean body-weight change of -18.7% at 72 wks. This is a trial average; individual results vary.

Search by medication, provider or treatment goal. Examples follow.

1 offers · US self-pay · 1 maintenance quotes

ProductProviderAdvertised priceMaintenance priceDetails
  • Wegovy HD pen (7.2 mg)

    Semaglutide · Manufacturer direct

    N
    NovoCare (Novo Nordisk)
    Advertised price$399/28 days

    28-day supply

    ≈ $427.50 per 30 days at this quoted rate

    Checked Sep 30, 2026

    self-pay cash, 7.2 mg dose

    Maintenance price$399/28 days

    At 7.2 mg

    28-day supply

    ≈ $427.50 per 30 days at this quoted rate

    Checked Sep 30, 2026

    View offer
    Price conditions & sourceChecked Sep 30, 2026

    One box contains four weekly pens. This is the HD maintenance dose, not a treatment starting dose. The $199 introduction applies only to 0.25 and 0.5 mg standard Wegovy. Prescription, eligibility and restrictions apply.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Ingredient-level FDA shortage report:No shortage reportedOpen record
    Read the advertised-price source

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.